Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy

Exclusion Criteria

• •The key criteria are listed below.
• •Patients in whom the possibility could not be ruled out that the current symptoms were symptoms of a disease requiring differential diagnosis, such as cervical spondylosis and multifocal motor neuropathy
• •Patients undergoing treatment for malignancy.
• •Patients who have presence of clinically significant liver, heart, or renal disease requiring hospitalization (except ALS) and infections requiring antibiotics. Patients who have a problem in general condition and are judged ineligible by the Investigator
• •Body mass index (BMI) of \<15.0 or \>30.0, or a body weight of \<40 kg
• •Patients judged by the investigator (or subinvestigator) to be unsuitable for the study for any other reason